{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:37:43Z","timestamp":1771684663558,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19677-1","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:18Z","timestamp":1760363898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of point-of-care Alere Pima CD4 test for low CD4 cell counts test in Uganda"],"prefix":"10.1038","volume":"15","author":[{"given":"Godfrey Pizaroh","family":"Mujuzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enock","family":"Wekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ocung","family":"Guido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Baveewo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan K.","family":"Nakayaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Karamagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"6","key":"19677_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1542\/peds.2022-059013","volume":"151","author":"JG Rosen","year":"2023","unstructured":"Rosen, J. G., Muraleetharan, O., Srivastava, M. & Walker, A. Pediatric antiretroviral therapy coverage and AIDS deaths in the treat all era. Pediatrics 151 (6), 13. https:\/\/doi.org\/10.1542\/peds.2022-059013 (2023).","journal-title":"Pediatrics"},{"issue":"2","key":"19677_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/COH.0000000000000348","volume":"12","author":"N Ford","year":"2017","unstructured":"Ford, N., Chiller, T., Greene, G., Meintjes, G. & Vitoria, M. The evolving role of CD4 cell counts in HIV care. Curr. Opin. HIV AIDS. 12 (2), 123\u2013128 (2017).","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"7","key":"19677_CR3","doi-asserted-by":"publisher","first-page":"e0218555","DOI":"10.1371\/journal.pone.0218555","volume":"14","author":"KA Stafford","year":"2019","unstructured":"Stafford, K. A. et al. Evaluation of the clinical outcomes of the test and treat strategy to implement treat all in nigeria: results from the Nigeria Multi-Center ART study. PLoS ONE. 14 (7), e0218555 (2019).","journal-title":"PLoS ONE"},{"issue":"2","key":"19677_CR4","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1097\/QAI.0b013e31825eec60","volume":"61","author":"BA Larson","year":"2012","unstructured":"Larson, B. A. et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care. J. Acquir. Immune Defic. Syndr. 61 (2), e13\u2013e17 (2012).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"15","key":"19677_CR5","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/QAD.0000000000002627","volume":"34","author":"R Lebelonyane","year":"2020","unstructured":"Lebelonyane, R. et al. Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes. AIDS Lond. Engl. 34 (15), 2223\u20132230 (2020).","journal-title":"AIDS Lond. Engl."},{"key":"19677_CR6","unstructured":"World Health Organization. Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. https:\/\/iris.who.int\/handle\/10665\/255884 (World Health Organization, 2017)."},{"issue":"6","key":"19677_CR7","doi-asserted-by":"publisher","first-page":"e1273","DOI":"10.1093\/cid\/ciab222","volume":"73","author":"E Brazier","year":"2021","unstructured":"Brazier, E. et al. Effects of National adoption of treat-all guidelines on pre-antiretroviral therapy (ART) CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clin. Infect. Dis. 73 (6), e1273\u2013e1281 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"19677_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2021.09.001","volume":"140","author":"E Zaniewski","year":"2021","unstructured":"Zaniewski, E. et al. Regression discontinuity analysis demonstrated varied effect of treat-all on CD4 testing among Southern African countries. J. Clin. Epidemiol. 140, 101\u2013110 (2021).","journal-title":"J. Clin. Epidemiol."},{"key":"19677_CR9","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/cid\/ciaa261","volume":"71","author":"E Nasuuna","year":"2020","unstructured":"Nasuuna, E. et al. Reduction in baseline CD4 count testing following human immunodeficiency virus treat all adoption in Uganda. Clin. Infect. Dis. 71, 2497\u20132499 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"19677_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12879-024-09524-5","volume":"24","author":"M Baldeh","year":"2024","unstructured":"Baldeh, M. et al. Advanced HIV disease and associated factors among young people aged 15\u201324 years at a tertiary hospital in Sierra leone: a cross-sectional study. BMC Infect. Dis. 24, 611 (2024).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"19677_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0b013e3181e93071","volume":"55","author":"S Mtapuri-Zinyowera","year":"2010","unstructured":"Mtapuri-Zinyowera, S. et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J. Acquir. Immune Defic. Syndr. 55 (1), 1\u20137 (2010).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"19677_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12916-015-0396-2","volume":"13","author":"LE Scott","year":"2015","unstructured":"Scott, L. E. et al. A meta-analysis of the performance of the Pima CD4 for point of care testing. BMC Med. 13, 168 (2015).","journal-title":"BMC Med."},{"key":"19677_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1588-y","volume":"16","author":"MD Pham","year":"2016","unstructured":"Pham, M. D. et al. Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review. BMC Health Serv. Res. 16, 1 (2016).","journal-title":"BMC Health Serv. Res."},{"key":"19677_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","volume":"3","author":"NM Buderer","year":"1996","unstructured":"Buderer, N. M. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad. Emerg. Med. 3, 895\u2013900 (1996).","journal-title":"Acad. Emerg. Med."},{"issue":"21","key":"19677_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.15585\/mmwr.mm6621a3","volume":"66","author":"AF Auld","year":"2017","unstructured":"Auld, A. F. et al. Trends in prevalence of advanced HIV disease at antiretroviral therapy enrollment\u201410 countries, 2004\u20132015. Morb Mortal. Wkly. Rep. 66 (21), 558\u2013563 (2017).","journal-title":"Morb Mortal. Wkly. Rep."},{"key":"19677_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fpubh.2023.1187274","volume":"11","author":"L Mugenyi","year":"2023","unstructured":"Mugenyi, L. et al. Effect of the universal test and treat policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda. Front. Public. Health. 11, 274. https:\/\/doi.org\/10.3389\/fpubh.2023.1187274 (2023).","journal-title":"Front. Public. Health"},{"issue":"2","key":"19677_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(14)70896-5","volume":"15","author":"N Ford","year":"2014","unstructured":"Ford, N. et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect. Dis. 15 (2), 241\u2013247 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"19677_CR18","doi-asserted-by":"publisher","first-page":"e88928","DOI":"10.1371\/journal.pone.0088928","volume":"9","author":"RM Galiwango","year":"2014","unstructured":"Galiwango, R. M. et al. Field evaluation of PIMA point-of-care CD4 testing in rakai, Uganda. PLoS ONE. 9, e88928 (2014).","journal-title":"PLoS ONE"},{"key":"19677_CR19","doi-asserted-by":"crossref","unstructured":"Nalintya, E. et al. The diagnostic performance of the visitect advanced disease point-of-care CD4 platform: A pragmatic, mixed-methods, multisite validation, costing, and qualitative analysis. J. Acquir. Immune Defic. Syndr. 97 (4), 387\u2013396 (2024).","DOI":"10.1097\/QAI.0000000000003505"},{"key":"19677_CR20","doi-asserted-by":"publisher","unstructured":"Evaluation of PIMATM CD4 system for decentralization of immunological monitoring of HIV-infected patients in Senegal. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0154000.","DOI":"10.1371\/journal.pone.0154000"},{"issue":"4","key":"19677_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/aid.2018.0223","volume":"35","author":"A Namuniina","year":"2019","unstructured":"Namuniina, A. et al. Field performance of PIMA point-of-care machine for CD4 enumeration under a mobile HIV counseling and testing program in remote fishing communities of lake victoria, Uganda. AIDS Res. Hum. Retroviruses. 35 (4), 382\u2013387 (2019).","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"2","key":"19677_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/picr.PICR_41_18","volume":"9","author":"P Ranganathan","year":"2018","unstructured":"Ranganathan, P. & Aggarwal, R. Understanding the properties of diagnostic tests\u2014Part 2: likelihood ratios. Perspect. Clin. Res. 9 (2), 99\u2013102 (2018).","journal-title":"Perspect. Clin. Res."},{"issue":"1","key":"19677_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-4-1","volume":"4","author":"DM Moore","year":"2007","unstructured":"Moore, D. M. et al. Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Res. Ther. 4 (1), 1 (2007).","journal-title":"AIDS Res. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19677-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19677-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19677-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:19Z","timestamp":1760363899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19677-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19677"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19677-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received ethical clearance from the School of Medicine Research and Ethical Committee (SOMREC), Makerere University College of Health Sciences, Kampala, granted in March 2015. Administrative clearance to conduct the study was also obtained from Mildmay Uganda. Written informed consent was sought from each volunteer before being enrolled into the study. Laboratory results were availed to the attending doctors for appropriate management of the patients. Information was coded and stored in password protected data bases and \/or lockable drawers accessible by only authorized personnel.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"35706"}}